Artificial heart lung machines market is driven by rising prevalence of heart diseases among individuals across the globe. In addition, increasing awareness about cardiovascular devices and growth in geriatric population are expected to drive growth of the global market over the forecast period. Moreover, advancements in technologies and improvement in healthcare facilities is also anticipated to boost growth of the global artificial heart lung machines market over the forecast period. Nevertheless, the key players are investing in research and development activities to order to develop new models of oxygenator pumps. These activities lead to development modular heart-lung machines which are cost- safe, effective, and user-friendly in nature.Artificial Heart Lung Machines Market was valued at US$ 374.2 million in 2024 and is projected to grow at a CAGR of 5.3% to reach US$ 598.3 million by 2034.

The report "Artificial Heart Lung Machines Market, By Type (Single Roller Pump and Double Roller Pump), By Application (Cardiac Surgery, Lung Transplantation Operations, and Acute Respiratory Failure Treatment), and Region - Global Forecast to 2034"

Key Highlights:

• May 2018, Terumo Aortic launched first implants of the RelayBranch Thoracic Stent-Graft System. This system assists safety and efficiency in patients with thoracic aortic pathologies requiring treatment proximal to the origin of the innominate artery.

Key Market Insights from the report:          

Artificial Heart Lung Machines Market was valued at US$ 374.2 million in 2024 and is projected to grow at a CAGR of 5.3% to reach US$ 598.3 million by 2034. The market report has been segmented on the basis of type, application, and region.

• By type, the global artificial heart lung machines market is segmented into single roller pump and double roller pump.
• By application, the global artificial heart lung machines market is categorized into cardiac surgery, lung transplantation operations, and acute respiratory failure treatment. Cardiac surgery application segment is expected to witness significant growth over the forecast period, owing to rise in the number of heart transplants, open-heart surgeries, and lung surgeries across the globe.
• By region, in 2017, North America accounted for significant global market, owing to rising number of heart transplants, cardiac surgeries, lung transplants, and strong health care infrastructure. Europe held a key share of the artificial heart-lung machine market in 2017, due to rising cardiac surgeries and number of transplantation cases. In addition, the growth is also attributed due to presence of prominent market players and robust health care infrastructure. Asia Pacific is anticipated to show significant growth over the forecast period, owing to increasing population, rise in the incidence of cardiovascular diseases, development in health care infrastructure, and presence of prominent market players.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Artificial heart lung machines Market”, By Type (Single Roller Pump and Double Roller Pump), By Application (Cardiac Surgery, Lung Transplantation Operations, and Acute Respiratory Failure Treatment), and by Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - forecast till 2034"

The prominent player operating in the global artificial heart lung machines market includes Medtronic Inc., Sorin Group, MAQUET GmbH & Co. KG, Terumo Corporation, C. R. Bard, Inc., Edwards Lifesciences LLC, Braile Biomedica, Inc., Tianjin Medical, SynCardia Systems, Inc., and Jarvik Heart, Inc.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com